ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 30 filers reported holding ALLENA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $581,000 | -34.3% | 980,200 | 0.0% | 0.29% | -27.6% |
| Q3 2021 | $884,000 | -8.6% | 980,200 | +31.7% | 0.40% | +10.6% |
| Q2 2021 | $967,000 | -29.0% | 744,200 | -24.1% | 0.36% | -45.5% |
| Q1 2021 | $1,362,000 | +108.6% | 980,200 | +92.1% | 0.66% | +27.7% |
| Q4 2020 | $653,000 | +7.9% | 510,200 | +24.8% | 0.52% | +4.2% |
| Q3 2020 | $605,000 | +50.1% | 408,840 | +60.3% | 0.50% | +150.5% |
| Q2 2020 | $403,000 | +307.1% | 255,000 | +148.1% | 0.20% | +224.6% |
| Q1 2020 | $99,000 | -85.2% | 102,794 | -57.9% | 0.06% | -81.3% |
| Q4 2019 | $667,000 | – | 244,186 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 2,263,365 | $15,889,000 | 50.04% |
| TRV GP II, LLC | 2,790,964 | $19,593,000 | 12.78% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $23,379,000 | 5.63% |
| Partner Investment Management, L.P. | 296,961 | $2,085,000 | 2.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 431,193 | $3,027,000 | 0.28% |
| PFM Health Sciences, LP | 1,463,208 | $10,272,000 | 0.23% |
| Perceptive Advisors | 132,300 | $929,000 | 0.03% |
| Fosun International Ltd | 29,877 | $209,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 83,200 | $584,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 343,574 | $2,412,000 | 0.01% |